FDA Inspection 983047 — Theravant Corporation
The FDA completed an inspection of Theravant Corporation on March 28, 2016 in Livermore, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 28, 2016
- Fiscal Year
- 2016
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Livermore, CA (United States)